Eagle Pharmaceuticals Inc
NASDAQ:EGRX

Watchlist Manager
Eagle Pharmaceuticals Inc Logo
Eagle Pharmaceuticals Inc
NASDAQ:EGRX
Watchlist
Price: 0.45 USD Market Closed
Market Cap: 5.8m USD

Wall Street
Price Targets

EGRX Price Targets Summary
Eagle Pharmaceuticals Inc

There are no price targets for EGRX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Eagle Pharmaceuticals Inc Competitors:
Price Targets
CRVO
Diffusion Pharmaceuticals Inc
170% Upside
PTCT
PTC Therapeutics Inc
6% Upside
IVA
Inventiva SA
224% Upside
BMRN
Biomarin Pharmaceutical Inc
53% Upside
MDGL
Madrigal Pharmaceuticals Inc
1% Upside
CNTB
Connect Biopharma Holdings Ltd
195% Upside
PRME
Prime Medicine Inc
85% Upside
TLX
Telix Pharmaceuticals Ltd
128% Upside

Revenue
Forecast

Revenue Estimate
Eagle Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Eagle Pharmaceuticals Inc's revenue is 42%. The projected CAGR for the next 3 years is -10%.

42%
Past Growth
-10%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Eagle Pharmaceuticals Inc

The compound annual growth rate of Eagle Pharmaceuticals Inc's operating income for the next 3 years is -21%.

N/A
Past Growth
-21%
Estimated Growth
Estimates Accuracy
-40%
Average Miss

Net Income
Forecast

Net Income Estimate
Eagle Pharmaceuticals Inc

The compound annual growth rate of Eagle Pharmaceuticals Inc's net income for the next 3 years is 4%.

N/A
Past Growth
4%
Estimated Growth
Estimates Accuracy
-51%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EGRX's stock price target?
Not Available

EGRX doesn't have any price targets made by Wall Street professionals.

What is Eagle Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-10%

For the last 8 years the compound annual growth rate for Eagle Pharmaceuticals Inc's revenue is 42%. The projected CAGR for the next 3 years is -10%.

What is Eagle Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
-21%

The compound annual growth rate of Eagle Pharmaceuticals Inc's operating income for the next 3 years is -21%.

What is Eagle Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
4%

The compound annual growth rate of Eagle Pharmaceuticals Inc's net income for the next 3 years is 4%.

Back to Top